|
Neurodevelopmental Risks Found With Seizure Drugs During Pregnancy
|
|
Pharmacists have additional information they can provide to expectant mothers with epilepsy who are concerned about their medications. A recent Stanford University School of Medicine–led study suggested that neurodevelopmental outcomes are usually not an issue with newer antiseizure medications. A secondary analysis, however, identified effects in some situations and raised some concerns about possible effects. Read more.
|
|
|
Study Indicates That Early MS Treatment Reduces Disability
|
|
|
The importance of treating multiple sclerosis (MS) early in the course of the disease has been underscored by a new study finding significant benefits. According to the researchers, their results provide class III evidence that earlier treatment of MS patients presenting with a first demyelinating event is associated with improved clinical outcomes. Read more.
|
|
Stepwise Approach to Implementing Drug Security Act
|
|
|
A decade ago, Congress mandated that new procedures be put in place this year to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. Find out why key pharmacy groups joined the call for the FDA to use a phased process for the Drug Quality and Security Act instead of full implementation.
|
|
|
PPI Use, Effectiveness of Oral Breast Cancer Therapies
|
|
Many patients are prescribed medications such as proton-pump inhibitors (PPIs) to manage gastrointestinal symptoms often caused by oral anticancer therapies. Find out why a South Korean study published in the Journal of the American Medical Association cautioned against that practice for breast cancer patients and how much PPI use was associated with decreased survival rates for patients on palbociclib.
|
|
.jpg)
